We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$21.8B
AUM Growth
+$3.36B
(+18%)
Cap. Flow
+$2.78B
Cap. Flow
% of AUM
12.74%
Top 10 Holdings %
Top 10 Hldgs %
12.04%
Holding
3,109
New
1,280
Increased
559
Reduced
519
Closed
699
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$363M |
| 2 |
Tencent Music
TME
|
+$184M |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$182M |
| 4 |
Baidu
BIDU
|
+$146M |
| 5 |
Gaotu Techedu
GOTU
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$204M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$189M |
| 3 |
Zoetis
ZTS
|
+$182M |
| 4 |
Guardant Health
GH
|
+$136M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.03% |
| 2 | Consumer Discretionary | 13.15% |
| 3 | Technology | 10.68% |
| 4 | Financials | 9.81% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATC
1276
DELISTED
Atotech Limited
ATC
| $2.21M | 0.01% |
+109,072
| New | +$2.23M |
|
|
CNR
1277
Core Natural Resources Inc
CNR
$4.01B
| $2.21M | 0.01% |
226,994
+209,153
| +1,172% | +$2.04M |
|
1278
Roper Technologies
ROP
$38.8B
| $2.2M | 0.01% |
5,461
+1,506
| +38% | +$604K |
|
|
XM
1279
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $2.2M | 0.01% |
+66,717
| New | +$2.71M |
|
1280
Annaly Capital Management
NLY
$17.3B
| $2.19M | 0.01% |
+63,621
| New | +$2.15M |
|
|
BGRYW
1281
CALL
DELISTED
Berkshire Grey, Inc. Warrant
BGRYW
| $2.19M | 0.01% |
+215,572
| New | +$476K |
|
1282
TIM SA
TIMB
$9.5B
| $2.17M | 0.01% |
191,300
+69,848
| +58% | +$856K |
|
1283
Global Payments
GPN
$23.6B
| $2.17M | 0.01% |
+10,766
| New | +$2.14M |
|
1284
Sonoco
SON
$5.95B
| $2.17M | 0.01% |
34,201
+27,409
| +404% | +$1.67M |
|
1285
Beyond Meat
BYND
$272M
| $2.16M | 0.01% |
16,620
+6,704
| +68% | +$986K |
|
1286
Autodesk
ADSK
$50.6B
| $2.16M | 0.01% |
+7,779
| New | +$2.24M |
|
1287
Pacira BioSciences
PCRX
$1.05B
| $2.15M | 0.01% |
+30,624
| New | +$2.19M |
|
|
ATRI
1288
DELISTED
Atrion Corp
ATRI
| $2.15M | 0.01% |
3,345
-92
| -3% | -$61K |
|
1289
Canadian Pacific Kansas City
CP
$81.4B
| $2.14M | 0.01% |
28,000
+15,370
| +122% | +$1.11M |
|
|
OCFT
1290
DELISTED
OneConnect Financial Technology
OCFT
| $2.14M | 0.01% |
+14,456
| New | +$2.76M |
|
1291
CALL
NVIDIA
NVDA
$4.77T
| $2.14M | 0.01% |
+160,000
| New | +$2.15M |
|
1292
Avanos Medical
AVNS
| $2.13M | 0.01% |
+48,785
| New | +$2.29M |
|
1293
BeyondSpring
BYSI
$48.1M
| $2.13M | 0.01% |
192,556
+30,236
| +19% | +$391K |
|
1294
iShares US Medical Devices ETF
IHI
$3.14B
| $2.13M | 0.01% |
+38,610
| New | +$2.14M |
|
1295
Thomson Reuters
TRI
$45.6B
| $2.12M | 0.01% |
+22,996
| New | +$2.05M |
|
1296
Builders FirstSource
BLDR
$7.87B
| $2.12M | 0.01% |
+45,719
| New | +$1.95M |
|
|
MGP
1297
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $2.12M | 0.01% |
64,905
+42,371
| +188% | +$1.37M |
|
1298
Clorox
CLX
$12.1B
| $2.11M | 0.01% |
10,956
+8,071
| +280% | +$1.55M |
|
1299
Diana Shipping
DSX
$270M
| $2.11M | 0.01% |
+1,009,898
| New | +$1.98M |
|
1300
Vista Energy
VIST
$7.14B
| $2.11M | 0.01% |
823,745
+585,895
| +246% | +$1.59M |
|
Similar funds
Marshall Wace's Q1 2021 Portfolio in Review
As of Q1 2021, Marshall Wace held 3,109 positions worth $21.8B, up 18% from $18.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace deployed $2.78B of net new capital in Q1 2021, opening 1,280 new positions and adding to 559 existing holdings. Its largest new stake was Paramount Global Class B: 5,936,494 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $204M trimmed.
- Marshall Wace's largest Q1 2021 buy was Paramount Global Class B: 5,936,494 shares worth $268M.
- Marshall Wace added most to Farfetch Limited Class A Ordinary Shares in Q1 2021, an estimated $182M increase.
- Marshall Wace's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $204M.
- Marshall Wace fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q1 2021, selling an estimated $76.2M.
- Marshall Wace's ten largest holdings make up 12% of its $21.8B portfolio in Q1 2021.
- Marshall Wace opened 1,280 new positions and closed 699 in Q1 2021.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $21.8B.
Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.